传奇生物:数据显示无需淋巴清除化疗或桥接治疗即可实现强劲的体内CAR-T扩增

美股速递
Jun 02

传奇生物公布的数据显示,其CAR-T疗法在无需进行淋巴清除化疗或桥接治疗的情况下,仍能在患者体内实现强劲的扩增。这一发现挑战了当前CAR-T治疗的标准预处理方案,可能为患者带来更安全、更便捷的治疗选择。数据揭示了该疗法独立于传统化疗支持而发挥效力的潜力,为未来优化治疗流程提供了新的方向。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10